Activation of NF-kB has been detected in both physiological and pathological atrophic conditions such as denervation, unloading, aging, cancer, sepsis, diabetes, and such atrophy can be reversed by pharmacologic or genetic NF-kB inhibition [47]. The gene discussed is NFKB1; the disease is cancer.